Pelagos Pharmaceuticals is developing a new class of therapeutics called "exercise mimetics" that modulate metabolic, mitochondrial and contractile pathways seen in health-promoting aerobic exercise. Our molecules are being specifically designed to address some of society’s most costly diseases including obesity, heart failure, cognitive decline and muscle wasting/frailty syndromes - with the ultimate goal of extending human healthspan & longevity. We are a seed-stage biotechnology startup with two active preclinical first-in-class discovery programs currently in the LEAD-to-IND phase. We are currently actively fundraising to deliver on two first-in-class development candidates in preparation for IND-enablement within the next 14-16months. Please join us in this new innovative endeavor by connecting with our Founders and/or Executive Team.
| Website | http://pelagospharma.com |
| Employees | 8 (2 on RocketReach) |
| Address | 3737 Buffalo Speedway Ste 1750, Houston, Texas 77030, US |
| Industry | Biotechnology Research |
| Keywords | Precision Medicine, Pharmaceutical Research, Targeted Therapy, Drug Discovery, Novel Therapeutics, Drug Development, Biotechnology, Molecular Medicine, Drug Design, Pharma Research, Innovative Treatments, Clinical Development, Biopharma, Therapeutics, New Medicines, Pharmaceutical, Life Sciences, Clinical Trials |
| Competitors | Novartis, Pfizer, Sanofi, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Alnylam Pharmaceuticals, Sarepta Therapeutics, Inc. +37 more (view full list) |
Looking for a particular Pelagos Pharma employee's phone or email?
Michele Cresap is the Associate Director, Discovery Sciences of Pelagos Pharma.
2 people are employed at Pelagos Pharma.
Pelagos Pharma is based in Houston, Texas.